Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels

Steffan T. Nawrocki, Jennifer S. Carew, Leslie Douglas, John L. Cleveland, Robin Humphreys, Janet A. Houghton

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels'. Together they form a unique fingerprint.

Medicine & Life Sciences